Dianthus Therapeutics, Inc. /DE/ (DNTH) Net income 2016–2025
Dianthus Therapeutics, Inc. /DE/ (DNTH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$162.3MFY2025 · since FY2016: -$9.4M → -$162.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$162.3M | -91.1% |
| FY2024 | -$85.0M | -95.1% |
| FY2023 | -$43.6M | -53.0% |
| FY2022 | -$28.5M | +60.0% |
| FY2021 | -$71.1M | +5.1% |
| FY2020 | -$74.9M | +2.4% |
| FY2019 | -$76.8M | -33.5% |
| FY2018 | -$57.5M | -62.1% |
| FY2017 | -$35.5M | -276.3% |
| FY2016 | -$9.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DNTH financial trends
DNTH RevenueDNTH Net marginDNTH Gross profitDNTH Gross marginDNTH Operating incomeDNTH Operating marginDNTH Operating cash flowDNTH Free cash flowDNTH Capital expendituresDNTH Return on equityDNTH Stock buybacksDNTH Dividends paidDNTH Total assetsDNTH Total liabilitiesDNTH Shareholders’ equityDNTH overview →